Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Employment agrmnt Quarterly results
|
ADMA BIOLOGICS, INC. (ADMA)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/03/2023 |
4
| Grossman Adam S (President and CEO) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Paid exercise price by delivering 18,718 shares
@ $3.58, valued at
$67k
|
|
10/03/2023 |
4
| LENZ BRIAN (EVP, CFO) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Paid exercise price by delivering 15,268 shares
@ $3.58, valued at
$54.7k
|
|
08/24/2023 |
4
| KWON YOUNG (Director) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Bought 25,000 shares
@ $3.9, valued at
$97.5k
|
|
08/23/2023 |
4
| Fong Bryant (Director) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Sold 1,433,304 shares
@ $3.8685, valued at
$5.5M
|
|
08/18/2023 |
4
| Grossman Adam S (President and CEO) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Sold 250,000 shares
@ $4.1534, valued at
$1M
|
|
08/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/17/2023 |
4
| LENZ BRIAN (EVP, CFO) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Sold 211,578 shares
@ $4.5975, valued at
$972.7k
Paid exercise price by delivering 631,078 shares
@ $4.61, valued at
$2.9M
Sold 178,184 shares
@ $4.4527, valued at
$793.4k
Exercised 97,395 options to buy
@ $1.67, valued at
$162.6k
Exercised 83,979 options to buy
@ $2.35, valued at
$197.4k
Exercised 85,416 options to buy
@ $2.92, valued at
$249.4k
Exercised 200,000 options to buy
@ $3.22, valued at
$644k
Exercised 150,000 options to buy
@ $3.71, valued at
$556.5k
Exercised 192,472 options to buy
@ $3.66, valued at
$704.4k
|
|
07/05/2023 |
4
| LENZ BRIAN (EVP, CFO) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Paid exercise price by delivering 15,268 shares
@ $3.69, valued at
$56.3k
|
|
07/05/2023 |
4
| Grossman Adam S (President and CEO) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Paid exercise price by delivering 20,051 shares
@ $3.69, valued at
$74k
|
|
04/04/2023 |
4
| LENZ BRIAN (EVP, CFO) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Paid exercise price by delivering 15,469 shares
@ $3.31, valued at
$51.2k
|
|
04/04/2023 |
4
| Grossman Adam S (President and CEO) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Paid exercise price by delivering 17,853 shares
@ $3.31, valued at
$59.1k
|
|
03/08/2023 |
4
| Grossman Adam S (President and CEO) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Paid exercise price by delivering 4,018 shares
@ $3.42, valued at
$13.7k
Paid exercise price by delivering 14,412 shares
@ $3.42, valued at
$49.3k
Paid exercise price by delivering 7,507 shares
@ $3.55, valued at
$26.6k
Granted 573,695 shares
@ $0 Paid exercise price by delivering 23,607 shares
@ $3.4, valued at
$80.3k
Granted 1,147,385 options to buy
@ $3.35, valued at
$3.8M
|
|
03/08/2023 |
4
| LENZ BRIAN (EVP, CFO) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Paid exercise price by delivering 1,559 shares
@ $3.42, valued at
$5.3k
Paid exercise price by delivering 7,927 shares
@ $3.42, valued at
$27.1k
Paid exercise price by delivering 5,000 shares
@ $3.55, valued at
$17.8k
Granted 135,175 shares
@ $0 Paid exercise price by delivering 16,965 shares
@ $3.4, valued at
$57.7k
Granted 270,345 options to buy
@ $3.35, valued at
$905.7k
|
|
03/08/2023 |
4
| Grossman Jerrold B (Director) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Granted 25,815 shares
@ $0 Granted 51,630 options to buy
@ $3.35, valued at
$173k
|
|
03/08/2023 |
4
| ELMS STEVE (Director) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Granted 25,815 shares
@ $0 Granted 51,630 options to buy
@ $3.35, valued at
$173k
|
|
03/08/2023 |
4
| Guiheen Lawrence P. (Director) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Granted 25,815 shares
@ $0 Granted 51,630 options to buy
@ $3.35, valued at
$173k
|
|
03/08/2023 |
4
| DEMSKI MARTHA J (Director) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Granted 25,815 shares
@ $0 Granted 51,630 options to buy
@ $3.35, valued at
$173k
|
|
03/08/2023 |
4
| KWON YOUNG (Director) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Granted 25,815 shares
@ $0 Granted 51,630 options to buy
@ $3.35, valued at
$173k
|
|
03/08/2023 |
4
| Fong Bryant (Director) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Granted 25,815 shares
@ $0 Granted 51,630 options to buy
@ $3.35, valued at
$173k
|
|
01/06/2023 |
4
| Grossman Adam S (President and CEO) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Paid exercise price by delivering 166,867 shares
@ $3.87, valued at
$645.8k
|
|
01/06/2023 |
4
| LENZ BRIAN (EVP, CFO) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Paid exercise price by delivering 114,222 shares
@ $3.87, valued at
$442k
|
|
12/09/2022 |
4
| LENZ BRIAN (EVP, CFO) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Bought 6,993 shares
@ $2.86, valued at
$20k
|
|
12/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/04/2022 |
4
| LENZ BRIAN (EVP, CFO) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Paid exercise price by delivering 73,678 shares
@ $2.43, valued at
$179k
|
|
05/13/2022 |
4
| LENZ BRIAN (EVP, CFO) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Paid exercise price by delivering 51,965 shares
@ $1.43, valued at
$74.3k
|
|
05/13/2022 |
4
| Grossman Adam S (President and CEO) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Paid exercise price by delivering 70,004 shares
@ $1.43, valued at
$100.1k
|
|
03/25/2022 |
4
| LENZ BRIAN (EVP, CFO) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Paid exercise price by delivering 37,178 shares
@ $1.46, valued at
$54.3k
|
|
03/25/2022 |
4
| Grossman Adam S (President and CEO) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Paid exercise price by delivering 50,539 shares
@ $1.46, valued at
$73.8k
|
|
03/09/2022 |
4
| KWON YOUNG (Director) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Granted 26,586 shares
@ $0 Granted 53,172 options to buy
@ $1.67, valued at
$88.8k
|
|
03/09/2022 |
4
| ELMS STEVE (Director) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Granted 26,586 shares
@ $0 Granted 53,172 options to buy
@ $1.67, valued at
$88.8k
|
|
03/09/2022 |
4
| Guiheen Lawrence P. (Director) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Granted 26,586 shares
@ $0 Granted 53,172 options to buy
@ $1.67, valued at
$88.8k
|
|
03/09/2022 |
4
| Fong Bryant (Director) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Granted 26,586 shares
@ $0 Granted 53,172 options to buy
@ $1.67, valued at
$88.8k
|
|
03/09/2022 |
4
| LENZ BRIAN (EVP, CFO) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Granted 137,500 shares
@ $0 Granted 275,000 options to buy
@ $1.67, valued at
$459.3k
|
|
|
|
|